Clinical Trials Directory

Trials / Recruiting

RecruitingNCT05495048

Transvaginal NOSES Versus Conventional Laparoscopic Surgery for Right Hemicolectomy

Transvaginal Natural Orifice Specimen Extraction Surgery Versus Conventional Laparoscopic Surgery With Mini-laparotomy in Right Hemicolectomy for Colon Cancer: a Randomised, Controlled, Phase 3, Non-inferiority Trial (NOSES VIIIA Trial)

Status
Recruiting
Phase
N/A
Study type
Interventional
Enrollment
356 (estimated)
Sponsor
Shanghai Minimally Invasive Surgery Center · Academic / Other
Sex
Female
Age
18 Years – 75 Years
Healthy volunteers
Not accepted

Summary

It is controversial that totally laparoscopic right hemicolectomy with transvaginal natural orifice specimen extraction (NOSES VIIIA) can provide non-inferior oncological outcomes compared to conventional laparoscopic surgery with mini-laparotomy in the treatment of right colon cancer. We aim to carry out a multicenter, open-lable, parallel, non-inferiority, phase III, randomized controlled clinical trial, which enrolls 356 female patients with cT1-3NxM0 right colon adenocarcinoma. They are randomly assigned to the experimental group (NOSES VIIIA) or the control group (laparoscopic surgery with mini-laparotomy) in a 1:1 ratio. Perioperative indicators, pathological results, quality of life and cosmetic evaluation will be compared between the two groups. Then, a three-year follow-up of these patients will provide evidence for long-term oncological outcomes of NOSES VIIIA.

Conditions

Interventions

TypeNameDescription
PROCEDURENOSES VIIIAtotally laparoscopic right hemicolectomy with transvaginal natural orifice specimen extraction
PROCEDURElaparoscopic surgery with mini-laparotomylaparoscopic right hemicolectomy with trans-abdominal extraction from a mini-laparotomy

Timeline

Start date
2023-07-01
Primary completion
2028-12-31
Completion
2028-12-31
First posted
2022-08-10
Last updated
2024-02-26

Locations

1 site across 1 country: China

Source: ClinicalTrials.gov record NCT05495048. Inclusion in this directory is not an endorsement.